hit counter
Catabasis Pharmaceuticals, Inc. (CATB) Stock News Sentiment & Price - Sentifly
CATB - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



Catabasis Pharmaceuticals, Inc. (CATB)

USA
Biotechnology
NASDAQ
CATB Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
CATB Latest news
Benzinga
Neutral
Catabasis Renames As Astria Therapeutics With New Disease Focus
2021-09-08 14:37

Once-struggling, Catabasis Pharmaceuticals Inc (NASDAQ: CATB) is looking to hit the reset button with a new name and focus. Catabasis has been dragging for several years, weighed down mainly by the failure of the edasalonexent program in Duchenne muscular dystrophy.

Business Wire
Neutral
Catabasis Pharmaceuticals Announces New Company Name, Astria Therapeutics, Highlighting New Company Focus
2021-09-08 08:00

BOSTON--(BUSINESS WIRE)--Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a biopharmaceutical company developing STAR-0215 for the treatment of hereditary angioedema (HAE), today announced its new name, Astria Therapeutics, Inc. (“Astria” or the “Company”). The name Astria originates from the Greek word for star, reflecting the Company's commitment to having patients serve as guiding stars. Astria's mission is to bring hope with life-changing therapies to patients and families. Astria expects to

Pulse2
Neutral
Catabasis Pharmaceuticals Shares: 1-For-6 Split Goes Into Effect
2021-08-20 14:07

Catabasis Pharmaceuticals Inc (NASDAQ: CATB) deployed a reverse stock split of its shares of common stock at a ratio of 1-for-6. These are the details.

Business Wire
Neutral
Catabasis Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides a Corporate Update
2021-08-09 16:10

BOSTON--(BUSINESS WIRE)--Catabasis Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides a Corporate Update

Business Wire
Neutral
Catabasis Pharmaceuticals to Present at 2021 Wedbush PacGrow Healthcare Conference
2021-08-04 08:00

BOSTON--(BUSINESS WIRE)--Catabasis Pharmaceuticals To Present At 2021 Wedbush PacGrow Healthcare Conference

Business Wire
Neutral
Catabasis Pharmaceuticals To Present At Ladenburg Thalmann 2021 Healthcare Conference
2021-07-07 08:00

BOSTON--(BUSINESS WIRE)--Catabasis will present information on its lead program QLS-215 at the Ladenburg Thalmann 2021 Healthcare Conference.

Seeking Alpha
Neutral
Catabasis Pharmaceuticals: Transformation Through Quellis Biosciences Acquisition
2021-06-30 02:24

Catabasis Pharmaceuticals: Transformation Through Quellis Biosciences Acquisition

Benzinga
Neutral
Why Kindred Biosciences, Aprea, Catabasis And Inhibikase Are Moving Today
2021-06-16 12:30

Kindred Biosciences, Inc. (NASDAQ: KIN), Aprea Therapeutics, Inc. (NASDAQ: APRE), Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB) and Inhibikase Therapeutics, Inc. (NASDAQ: IKT) are among the biggest biopharma movers on Wednesday. Kindred Flies On Buyout: Kindred announced an agreement to be bought by Elanco Animal Health Incorporated (NYSE: ELAN) for $9.25 per share, or approximately $440 million.

Pulse2
Positive
CATB Stock Price Increases Over 40% Pre-Market: Why It Happened
2021-06-16 04:42

The stock price of Catabasis Pharmaceuticals Inc (NASDAQ: CATB) increased by over 40% pre-market. This is why it happened.

Business Wire
Neutral
Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences
2021-05-14 08:00

BOSTON--(BUSINESS WIRE)--Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences

Loading more news...